HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of khellin and 308-nm excimer lamp in the treatment of severe alopecia areata in a child.

Abstract
Alopecia areata (AA) is an autoimmune inflammatory disorder of hair, characterized by non-scarring hair loss. A 308-nm excimer lamp (EL) has been reported as one effective modality in the treatment of AA. Khellin is a furanochromone photosensitizer whose chemical structure is close to psoralens and has previously proven its efficacy in vitiligo in association with ultraviolet A. We evaluated the efficacy and safety of a combination of topical khellin and 308-nm EL in the treatment of a refractory ophiasic AA, of 1-year evolution, in a 5-year-old boy. Treatment consisted in topical application of khellin 45 mn before irradiation with EL (starting dose 50 mJ/cm2) twice a week for 3 months. The result was a complete regrowth of hair with no recurrence 1 year later. Further studies should be carried out to confirm this promising result and to propose khellin-excimer as a new alternative treatment for resistant cases of AA in children.
AuthorsSamy Fenniche, Houda Hammami, Anissa Zaouak
JournalJournal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology (J Cosmet Laser Ther) Vol. 20 Issue 3 Pg. 156-158 (Jun 2018) ISSN: 1476-4180 [Electronic] England
PMID29020475 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Photosensitizing Agents
  • Khellin
Topics
  • Alopecia Areata (drug therapy)
  • Child, Preschool
  • Humans
  • Khellin (therapeutic use)
  • Lasers, Excimer (therapeutic use)
  • Male
  • Photochemotherapy (methods)
  • Photosensitizing Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: